Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
Status:
Completed
Trial end date:
2020-07-29
Target enrollment:
Participant gender:
Summary
To determine whether use of detemir compared to neutral protamine hagedorn (NPH) decreases
rates of composite neonatal outcome and maternal hypoglycemia events in women with Type 2
Diabetes Mellitus (T2DM).
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston